Tiny implant to unmask silent heart rhythm disorder in valve patients

NCT ID NCT07377799

Not yet recruiting Knowledge-focused Sponsor: Rigshospitalet, Denmark Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will implant a small heart monitor under the skin of 100 people with moderate-to-severe mitral valve regurgitation who have few or no symptoms. The device will track heart rhythms for up to three years to find hidden atrial fibrillation that standard tests might miss. Researchers hope to learn how common these silent episodes are and whether they raise the risk of stroke or other problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could improve detection of hidden atrial fibrillation in mitral regurgitation patients, potentially guiding earlier treatment to prevent strokes.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to direct patient benefits, and the small size (100 patients) limits how widely the findings can be applied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation mitral valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF) MITRAL REGURGITATION

Contacts and locations

Locations

Rigshospitalet

Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.